share_log

AbbVie to Present at Citi's 2024 Global Healthcare Conference

AbbVie to Present at Citi's 2024 Global Healthcare Conference

艾伯維公司將在花旗銀行2024年全球醫療健康大會上進行演講。
艾伯維公司 ·  11/25 13:00

NORTH CHICAGO, Ill., Nov. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024. Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., executive vice president, Research & Development and chief scientific officer, will present at 9:15 a.m. Central time.

伊利諾伊州北芝加哥,2024年11月25日/ PRNewswire/ - 艾伯維公司(紐交所:ABBV) 將參加2024年12月3日星期二Citi全球醫療會議。 首席財務官Scott T. Reents,首席商務官Jeffrey R. Stewart 和首席科學官及研發執行副總裁Roopal Thakkar女士將於美國中部時間上午9:15參會。

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

演示的現場錄音網絡廣播將通過艾伯維公司的投資者關係網站investors.abbvie.com 訪問。 當天晚些時候將提供演講節目的存檔版本。

About AbbVie

關於艾伯維公司

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at . Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

艾伯維公司的使命是發現和提供能夠解決當今嚴重健康問題並解決明天的醫療挑戰的創新藥物和解決方案。我們致力於在幾個重要治療領域 – 免疫學、腫瘤學、神經科學和眼科領域及我們的愛爾蘭雅品牌組合中產生顯著影響。有關艾伯維公司的更多信息,請訪問我們的網站 。在LinkedIn上關注@abbvie,Instagram, Facebook, Instagram, X (曾用名Twitter),,和 YouTube。

big

SOURCE AbbVie

消息來源 艾伯維

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論